What Is Demodex Blepharitis?
Demodex blepharitis is an inflammatory eyelid condition caused by tiny mites, Demodex folliculorum and Demodex brevis, that naturally live on human skin. These mites are part of the normal microflora around eyelashes and oil glands, but when their numbers grow too high, they can irritate the eyelid margin and ocular surface.
This overgrowth can disrupt oil gland function, contribute to inflammation, and trigger symptoms of blepharitis aka inflammation of the eyelid margin.
How Common Is It?
Recent clinical observations suggest Demodex blepharitis is extremely common among eye care patients. Two large U.S. clinical studies found signs of Demodex infestation in 55–58% of patients seen in eye clinics.
Meaning: More than half of routine eye care patients may have signs of Demodex blepharitis, even if they weren’t originally seeking care for it.
What Causes Demodex to Become a Problem?
Demodex mites normally live on our skin without causing issues. Problems arise when:
- Mite populations grow excessively on the eyelids
- Tear film and oil gland function become disrupted
- Skin or immune changes make inflammation more likely
Factors such as rosacea, chronic dry eye, aging skin, or poor eyelid hygiene can contribute to mite overgrowth and symptom development.
What Are the Most Common Symptoms?
Patients with Demodex blepharitis commonly experience:
• Itchy, burning eyelids
• Gritty or foreign body sensation
• Redness of the eyelid margin
• Crusty debris or “collarettes” at the base of eyelashes
• Eyelid irritation that worsens in the morning or throughout the day
The presence of collarettes, waxy, cylindrical debris at the lash base, is considered pathognomonic (highly indicative) of Demodex blepharitis and is often used by clinicians to diagnose it without invasive lash pulls.
How Is It Diagnosed?
A thorough eye exam by an optometrist or ophthalmologist is the first step. Because Demodex mites are microscopic, clinicians typically look for:
- Lid margin inflammation
- Collarettes at the base of lashes
- Reddened eyelid margins
- Eyelid irritation consistent with blepharitis
In many settings, the presence of collarettes alone strongly suggests Demodex without requiring eyelash removal.
What Are the Best Treatments Available Today?
1. Prescription Treatment: Lotilaner Ophthalmic Solution (XDEMVY®)
One of the most significant advances in treatment is lotilaner ophthalmic solution 0.25%, which has demonstrated effective eradication of mites and reduction of collarettes in clinical trials.
This FDA-approved option targets the mites directly, reducing both mite density and inflammatory signs that cause symptoms.
2. Eyelid Hygiene and Warm Compresses
Regular eyelid cleansing, warm compresses, and gentle massage help reduce symptoms and support oil gland function. These remain essential components of basic blepharitis care.
3. Adjunct Therapies
Some patients benefit from supplemental therapies — such as microblepharoexfoliation or adjunct treatments — especially when inflammation is significant. These are typically layered on top of first-line care.
When Should You See a Doctor?
If you have ongoing eye irritation, itchiness, redness, or crusting around your lashes that doesn’t improve with basic eye hygiene, it’s worth scheduling an eye exam. Persistent symptoms may indicate Demodex blepharitis or another underlying condition requiring targeted treatment.
A comprehensive evaluation can differentiate Demodex blepharitis from other causes of dry eye and eyelid disease and guide the most effective treatment plan.
Takeaway
Demodex blepharitis is common, underdiagnosed, and treatable. Because symptoms can mimic other ocular surface conditions, many people living with discomfort assume it’s just “dry eye.”
If you’re struggling with persistent eyelid irritation, ask your eye care provider about Demodex blepharitis and whether treatments like lotilaner ophthalmic solution might be right for you.
- Nanavaty MA, et al. Prevalence of Demodex blepharitis among eye clinic patients. Eye. 2025.
- Ophthalmology Times. Screening for Demodex blepharitis: Integrating best practices. 2025.
- Czępińska-Myszura A. Pharmacotherapy of Demodex-associated blepharitis. Pharmacy. 2025.
- Lapid-Gortzak R. Advances in the diagnosis and treatment of Demodex blepharitis. Ophthalmology Times Europe. 2025.
- Senior-Fletcher DE. Treatment comparisons and eyelid hygiene strategies. Frontiers in Allergy. 2025.
- Alster Y. Emerging AZR 0.5% therapy in Demodex blepharitis. PMC Study. 2026.
